These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 16773520)
21. Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. Nakase H; Yamamoto S; Matsuura M; Honzawa Y; Chiba T Aliment Pharmacol Ther; 2010 Aug; 32(3):510-1. PubMed ID: 20636704 [No Abstract] [Full Text] [Related]
22. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]. Mocciaro F; Orlando A; Scimeca D; Cottone M Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405 [TBL] [Abstract][Full Text] [Related]
23. Infliximab for induction and maintenance therapy for ulcerative colitis. Moss AC; Farrell RJ Gastroenterology; 2006 Nov; 131(5):1649-51; discussion 1651. PubMed ID: 17067595 [No Abstract] [Full Text] [Related]
24. Infliximab for ulcerative colitis in children and adolescents. McGinnis JK; Murray KF J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529 [TBL] [Abstract][Full Text] [Related]
25. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Feagan BG; Reinisch W; Rutgeerts P; Sandborn WJ; Yan S; Eisenberg D; Bala M; Johanns J; Olson A; Hanauer SB Am J Gastroenterol; 2007 Apr; 102(4):794-802. PubMed ID: 17324131 [TBL] [Abstract][Full Text] [Related]
26. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Jakobovits SL; Jewell DP; Travis SP Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506 [TBL] [Abstract][Full Text] [Related]
27. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208 [TBL] [Abstract][Full Text] [Related]
28. Current management of severe ulcerative colitis. Caprilli R; Viscido A; Latella G Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544 [TBL] [Abstract][Full Text] [Related]
29. Rescue with infliximab and surgical outcomes for refractory ulcerative colitis. Actis GC; Pellicano R; Pinna-Pintor M; Rizzetto M J Am Coll Surg; 2007 Oct; 205(4):e3-4. PubMed ID: 17903716 [No Abstract] [Full Text] [Related]
30. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab]. Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078 [TBL] [Abstract][Full Text] [Related]
32. Infliximab or cyclosporine for severe ulcerative colitis. Hanauer SB Gastroenterology; 2005 Oct; 129(4):1358-9; author reply 1359. PubMed ID: 16230092 [No Abstract] [Full Text] [Related]